Latest filing published 14 Jun 2018 for Panbela Therapeutics, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
David B. Kaysen: trading record in brief
This profile gathers the share dealings of David B. Kaysen across 3 companies, led by Zevex International Inc, Uroplasty Inc and Panbela Therapeutics, Inc. Between 5 March 2006 and 16 May 2018, the trades on record add up to 15 filings.
The open-market side counts 5 purchases for €47k alongside 2 sales for €409k. The totals exclude 2 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 3 share grants and 5 option exercises. So far in 2018, the count stands at 1 purchase and no sales.
A typical purchase (the median) is worth €6,953.
Most recently, on 14 June 2018, the filings show an open-market purchase in Panbela Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David B. Kaysen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 sharesCommon StockSEC:0001437749-18-011850:0Canonical exit: 14 Aug 2018 (T+90)
- 50,000 sharesCommon StockSEC:0001437749-16-034509:0Canonical exit: 22 Sept 2016 (T+90)
- 51,775 shares0common stockSEC:0001140361-12-029547:0
- 1,500 shares@ US$6.57common stockSEC:0001209191-11-042736:0Canonical exit: 31 Oct 2011 (T+90)
- 12,550 shares0common stockSEC:0001140361-11-032131:0
- 20,300 shares0common stockSEC:0001209191-10-033660:0
- 3,000 shares@ US$3.06common stockSEC:0001209191-08-045174:0Canonical exit: 2 Nov 2008 (T+90)
- 14,250 shares@ US$3.50common stockSEC:0001209191-07-066271:0Canonical exit: 18 Feb 2008 (T+90)
- 10,000 shares@ US$3.63Common StockSEC:0000827056-06-000042:0
- 7,580 shares@ US$3.59Common StockSEC:0000827056-06-000042:1
- 17,580 shares@ US$23.26Common StockSEC:0000827056-06-000042:2
- 2,500 shares@ US$2.47CommonSEC:0000827056-06-000018:0
- 2,500 shares@ US$1.90CommonSEC:0000827056-06-000018:1
- 2,420 shares@ US$3.59CommonSEC:0000827056-06-000018:2
- 7,420 shares@ US$15.13CommonSEC:0000827056-06-000018:3
15 of 15 declarations
